The Latest Cardiac and Vascular News
BOSTON–(BUSINESS WIRE)–LuxCath, LLC, a medical device company developing a novel cardiac catheter ablation technology, today announced that Terry Ransbury has been appointed its Chief Technology Officer. Mr. Ransbury is a seasoned industry veteran who brings over 30 years of experience in research and development, specializing in electrophysiology and cardiac rhythm […]
BOSTON–(BUSINESS WIRE)–LuxCath, LLC will showcase the next generation of its proprietary OmniView™ light-guided catheter ablation system at the 2018 Heart Rhythm Society (HRS) conference in Boston, May 9 to 12 at the Boston Convention Center. The OmniView light-guided ablation catheter is the only technology that can see into tissue during cardiac […]
